No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading into the new year. Let's consider three that are among my favorites to buy: ...

Steel is a cyclical sector, and several catalysts could propel Nucor stock even higher through the cycle. However, there are ...

Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many ...

Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Gary James Richards, 79 of Franklin, IN and formerly of Greenwood, IN passed away on Sunday, December 7, 2025, at Compass Park in Franklin, IN.

The dramatic stock slump, which puts Novo Nordisk at a historically cheap valuation, reflects investor concern over future sales growth and competition, particularly from rival Eli Lilly & Co.

Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.